《Clinical And Experimental Allergy》雜志的最新年發文量為71篇。
這表明該刊在每年都會精選并發表一定數量的高質量文章，以保持其在過敏領域的學術影響力。
該刊聚焦于醫學-過敏領域的前沿研究，致力于推動該領域新技術和新知識的傳播與應用。同時它積極鼓勵研究人員詳細發表其高質量的實驗研究和理論成果。
該刊的平均審稿周期約為 一般,3-8周 。
Clinical And Experimental Allergy 雜志發文統計
文章名稱引用次數
- The use of omalizumab in allergen immunotherapy21
- Prenatal maternal psychosocial stress and offspring's asthma and allergic disease: A systematic review and meta-analysis20
- Severe asthma-A population study perspective18
- Adherence to treatment in allergic rhinitis using mobile technology. The MASK Study15
- The clinical relevance of lipid transfer protein14
- Local allergic rhinitis: Implications for management14
- High- and low-dose oral immunotherapy similarly suppress pro-allergic cytokines and basophil activation in young children13
- Genome-wide association study of inhaled corticosteroid response in admixed children with asthma12
- Insights in particulate matter-induced allergic airway inflammation: Focus on the epithelium12
- Diagnosis of concomitant inducible laryngeal obstruction and asthma11
國家/地區發文量
- England383
- USA137
- GERMANY (FED REP GER)65
- Netherlands63
- Sweden61
- France60
- Australia59
- Italy49
- Spain37
- Canada32
